Prof Emmanuel Seront presented the RENALUT trial, an international, multicenter...
A subgroup analysis presented at ESMO evaluated the clinical performance of...
A retrospective analysis of the UNITE study evaluated the efficacy of EV plus...
The CLEAR trial was a large phase III randomised study evaluating first-line...
The phase III POTOMAC trial investigated whether adding the PD-L1 inhibitor...
At the 2025 ESMO Congress, researchers presented a detailed analysis of...
In this video, Dr Annelies Verbiest, medical oncologist, discusses the key...
In this video, Dr Daan De Maeseneer, medical oncologist, discusses the results...
Dr Nieves Martínez-Chanzá, medical oncologist at the Jules Bordet Institute...
Prof Dr Emmanuel Seront presented a selection of proffered papers from the...